One small step in time, one giant leap for DMPK kind - a CRO perspective of the evolving core discipline of drug development.
Saved in:
| Title: | One small step in time, one giant leap for DMPK kind - a CRO perspective of the evolving core discipline of drug development. |
|---|---|
| Authors: | Kendrick JS; Labcorp Early Development Laboratories Inc, Harrogate, United Kingdom., Webber C; Labcorp Early Development Laboratories Inc, Huntingdon, United Kingdom. |
| Source: | Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2022 Aug; Vol. 52 (8), pp. 797-810. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 1306665 Publication Model: Print Cited Medium: Internet ISSN: 1366-5928 (Electronic) Linking ISSN: 00498254 NLM ISO Abbreviation: Xenobiotica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1366-5928 |
|---|---|
| DOI: | 10.1080/00498254.2022.2124389 |
